US2009043091A1PendingUtilityA1
Atm inhibitors
Est. expiryAug 13, 2023(expired)· nominal 20-yr term from priority
Inventors:Graeme Cameron Murray SmithNiall Morrison Barr MartinXiao-Ling Fan CockcroftIan Timothy Williams MatthewsKeith Allan MenearLaurent Jean Martin RigoreauMarc Geoffrey HummersoneRoger John Griffin
A61P 31/12A61P 35/00A61P 43/00A61P 35/02A61P 31/14A61P 31/18A61P 25/00A61P 25/08C07D 409/14C07D 417/14A61P 21/02C07D 495/04C07D 491/04C07D 413/04C07D 417/04C07D 409/04
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A compound of formula I: and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, wherein: R 1 and R 2 together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; and R N1 is selected from hydrogen, an optionally substituted C 1-7 alkyl group, an optionally substituted C 3-20 heterocyclyl group, an optionally substituted C 5-20 aryl group, an acyl group, an ester group and an amido group, and its use as a pharmaceutical.
Claims
exact text as granted — not AI-modified1 . A compound of formula III:
and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, wherein:
R 1 and R 2 together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms;
R C3 is of formula:
wherein r is 0 or 1, and q can be 1 or 2 when r is 0 and q is 1 when
r is 1, and
wherein R N4 and R N5 are independently selected from hydrogen, optionally substituted C 1-7 alkyl groups, optionally substituted C 3-20 heterocyclyl groups and optionally substituted C 5-20 aryl groups, or together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms.
2 . A compound according to claim 1 , wherein r=0.
3 . A compound according to claim 1 , wherein R N4 and R N5 are independently selected from hydrogen, optionally substituted C 1-7 alkyl groups, or together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms.
4 . A compound according to claim 3 , wherein one of R N4 and R N5 is an optionally substituted C 1-7 alkyl group, the other is preferably H, and the optional substituents are selected from hydroxy, amino, cyano, C 3-20 heterocylyl and C 5-20 aryl (more preferably C 5-7 aryl).
5 . A compound according to claim 1 , wherein one of R N4 and R N5 is of formula IIb:
wherein r is from 1 to 3; and
R N2 and R N3 are independently selected from hydrogen, optionally substituted C 1-7 alkyl groups, optionally substituted C 3-20 heterocyclyl groups and optionally substituted C 5-20 aryl groups, or together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms.
6 . A compound according to claim 5 , wherein R N2 and R N3 are independently selected from hydrogen, optionally substituted C 1-7 alkyl groups or together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms.
7 . A compound according to claim 1 , wherein R N4 and R N5 together form, along with the nitrogen atom to which they are attached, a ring selected from piperidine, homopiperidine, piperazine, homopiperazine and morpholino.
8 . A compound according to claim 7 , wherein the ring is piperazine or homopiperazine, and the other nitrogen ring atom is substituted by a group selected from an optionally substituted C 1-7 alkyl group, an optionally substituted C 3-20 heterocyclyl group, an optionally substituted C 5-20 aryl group, an acyl group, an ester group or an amido group.
9 . A compound of formula VI:
and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, wherein:
R 1 and R 2 together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; and
R C4 is of formula:
wherein r is 0 or 1, and q can be 1 or 2 when r is 0 and q is 1 when r is 1, and
wherein R N4 and R N5 are independently selected from hydrogen, optionally substituted C 1-7 alkyl groups, optionally substituted C 3-20 heterocyclyl groups and optionally substituted C 5-20 aryl groups, or together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms.
10 . A compound according to claim 9 , wherein r=0.
11 . A compound according to claim 9 , wherein R N4 and R N5 are independently selected from hydrogen, optionally substituted C 1-7 alkyl groups, or together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms.
12 . A compound according to claim 11 , wherein one of R N4 and R N5 is an optionally substituted C 1-7 alkyl group, the other is preferably H and the optional substituents are selected from hydroxy, halo, C 1-7 alkoxy, thiol, C 1-7 thioether, amino, ester, cyano, C 3-20 heterocylyl and C 5-20 aryl.
13 . A compound according to claim 9 , wherein, one of R N4 and R N5 is of formula IIb:
wherein r is from 1 to 3; and
R N2 and R N3 are independently selected from hydrogen, optionally substituted C 1-7 alkyl groups, optionally substituted C 3-20 heterocyclyl groups and optionally substituted C 5-20 aryl groups, or together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms.
14 . A compound according to claim 13 , wherein R N2 and R N3 are independently selected from hydrogen, optionally substituted C 1-7 alkyl groups or together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms.
15 . A compound according to claim 14 , wherein R N4 and R N5 together form, along with the nitrogen atom to which they are attached, a ring selected from piperidine, homopiperidine, piperazine, homopiperazine and morpholino.
16 . A compound according to claim 15 , wherein the ring is piperazine or homopiperazine, and the other nitrogen ring atom is substituted by a group selected from an optionally substituted C 1-7 alkyl group, an optionally substituted C 3-20 heterocyclyl group, an optionally substituted C 5-20 aryl group, an acyl group, an ester group and an amido group.
17 . A compound according to claim 1 , wherein R 1 and R 2 form, along with the nitrogen atom to which they are attached, a ring selected from morpholino and thiomorpholino.
18 . A compound according to claim 9 , wherein R 1 and R 2 form, along with the nitrogen atom to which they are attached, a ring selected from morpholino and thiomorpholino.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.